Page last updated: 2024-08-22

streptomycin and Breast Neoplasms

streptomycin has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Arioli, S; Balsari, A; Belmonte, B; Bertolotti, A; Bianchi, F; Bonizzi, A; Corsi, F; De Cecco, L; Di Modica, M; Fasano, E; Gargari, G; Guglielmetti, S; Regondi, V; Tagliabue, E; Tripodo, C; Triulzi, T; Villani, L	1

Other Studies

1 other study(ies) available for streptomycin and Breast Neoplasms

Article	Year
Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer. Cancer research, 2021, 04-15, Volume: 81, Issue:8 Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents, Immunological; Breast Neoplasms; Bridged-Ring Compounds; CD4-Positive T-Lymphocytes; Cyclophosphamide; Cytokines; Dendritic Cells; Doxorubicin; Fecal Microbiota Transplantation; Female; Gastrointestinal Microbiome; Granzymes; Humans; Immune System; Immunity, Mucosal; Interferons; Interleukin-12; Mice; Neoadjuvant Therapy; Nitric Oxide; Receptor, ErbB-2; Streptomycin; Taxoids; Trastuzumab; Treatment Outcome; Tumor Microenvironment; Vancomycin	2021

Article

Year

Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer.

Cancer research, 2021, 04-15, Volume: 81, Issue:8

Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents, Immunological; Breast Neoplasms; Bridged-Ring Compounds; CD4-Positive T-Lymphocytes; Cyclophosphamide; Cytokines; Dendritic Cells; Doxorubicin; Fecal Microbiota Transplantation; Female; Gastrointestinal Microbiome; Granzymes; Humans; Immune System; Immunity, Mucosal; Interferons; Interleukin-12; Mice; Neoadjuvant Therapy; Nitric Oxide; Receptor, ErbB-2; Streptomycin; Taxoids; Trastuzumab; Treatment Outcome; Tumor Microenvironment; Vancomycin

2021